Navigation Links
Toward controlling fungus that caused Irish potato famine
Date:1/19/2011

Scientists are reporting a key advance toward development of a way to combat the terrible plant diseases that caused the Irish potato famine and still inflict billions of dollars of damage to crops each year around the world. Their study appears in ACS' bi-weekly journal Organic Letters.

Teck-Peng Loh and colleagues point out that the Phytophthora fungi cause extensive damage to food crops such as potatoes and soybeans as well as to ornamental plants like azaleas and rhododendrons. One species of the fungus caused the Irish potato famine in the mid 1840s. That disaster resulted in nearly one million deaths from starvation and forced millions more people to flee Ireland for the United States and other countries. Still difficult to control despite the use of modern pesticides, the fungus continues to cause $6 billion in damage to global potato crops annually. Scientists, however, have isolated a key hormone, alpha-1, that allows Phytophthora to reproduce. The hormone exists in several different forms, and a synthetic version of the most biologically active form could provide the basis for developing a way to control the fungus and reduce its threat, the scientists suggest.

They describe an advance toward this goal, the synthesis of a particularly active form of the mating hormone called (3R,7R,11R,15R)-hormone alpha-1. The scientists also showed that they could make relatively large quantities of the hormone. The advance could open the door to an effective method to fight this ancient scourge, they suggest.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. Big city life may make residents lean toward green, study says
2. Tracing microbes between individuals towards personalized oral health care
3. Towards an efficient, effective and equitable REDD+
4. Progress toward treating infections by silencing microbes smart phones
5. Progress toward first commercial repellent for East Coasts stinker
6. Striding towards a new dawn for electronics
7. Toward the first nose drops to treat brain cancer
8. Ingredient in soap points toward new drugs for infection that affects 2 billion
9. Toward resolving Darwins abominable mystery
10. A step toward a new sunscreen?
11. Advance toward earlier detection of melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... SAN FRANCISCO and WARSAW, Poland , Nov. 30, 2016 ... sleeping. It is one of the most crucial aspects of recovery so we need ... host of serious health risks, including heart problems, high blood pressure, stroke, diabetes, and ... family and friends sleep and find a Christmas present that could help them to ... ...
(Date:11/29/2016)... Lithuania , Nov. 29, 2016 /PRNewswire/ ... biometric identification and object recognition technologies, today ... (SDK) for fingerprint recognition solutions that run ... a fingerprint template using less than 128KB ... in compact devices that have limited on-board ...
(Date:11/24/2016)... Cercacor today introduced Ember TM Sport ... non-invasively measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion ... in approximately 30 seconds. Smaller than a smartphone, using ... to key data about their bodies to help monitor ... Hemoglobin carries oxygen to muscles. When hemoglobin ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... ... 05, 2016 , ... This composition patent, U.S. Patent No. ... The composition claims are not limited to any particular process to make or ... carbon fibers, graphene, and other materials. A continuation application, U.S. Patent App. ...
(Date:12/5/2016)... , Dec. 5, 2016  Renova™ Therapeutics, ... congestive heart failure and other chronic diseases, announced ... the company as Chief Financial Officer (CFO), effective ... with 20 years of experience in financial management ... biotech and software companies. Most recently, Ms. Bovenizer ...
(Date:12/5/2016)... , December 5, 2016 The ... with almost $108 billion of revenue and some $890 ... were spent on global biopharmaceuticals, and this figure is ... Stock-Callers.com has lined up these four equities for assessment: ... Pharmaceuticals Inc. (NASDAQ: ACAD ), Acorda Therapeutics ...
(Date:12/2/2016)... ... ... In anticipation of AxioMed’s exclusive cleanroom manufacturing facility in ... Lubinski will be traveling to Switzerland from December 5-10. Mr. Lubinski will meet ... to discuss the benefits of a viscoelastic disc. AxioMed received CE mark in ...
Breaking Biology Technology: